Specificity of polyclonal anti-p53 IgG for isolation of the soluble p53 antigen from human serum

被引:0
|
作者
Sandler, B
Smirnoff, P
Tendelr, Y
Zinder, O
Zusman, R
Zusman, I
机构
[1] Hebrew Univ Jerusalem, Koret Sch Vet Med, Lab Teratol & Expt Oncol, IL-76100 Rehovot, Israel
[2] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Inst Biochem, IL-76100 Rehovot, Israel
[3] Rambam Med Ctr, Dept Clin Biochem, Haifa, Israel
关键词
affinity chromatography; IgG; p53; protein;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The possibility to use anti-p53 IgG for isolation of the soluble p53 antigen as a serological tumor marker has been shown in our previous studies. In order to prove the specificity of such IgG, we compared the effectiveness of columns with anti-p53 IgG and IgG isolated from non-treated rabbits (regular IgG). The gel fiberglass (GFG) columns for affinity chromatography were prepared separately with both types of IgG. The same serum was percolated simultaneously through both columns and the results of elution were compared. The total concentration of tumor-associated antigens (TAA) eluted from the serum of cancer patients was similar in both TAA mixtures isolated either with anti-p53 IgG or with the regular IgG. Differences are manifest in the content of total proteins and amount of each eluted protein: a mixture eluted with the regular IgG contains several proteins whereas the anti-p53 IgG isolated only two proteins, p64 and p53. The amount of the soluble p53 antigen isolated from the cancer serum was significantly higher when it was isolated with anti-p53 IgG. The method developed in our laboratory was shown to be highly specific both to isolate proteins related to cancer (p53) and non-cancer disorders (p64). Data presented in this report show that such specificity can be achieved only if the anti-p53 IgG is used: the regular IgG obtained from non-treated animals isolate many proteins among which the concentration of specific p53 protein is lost.
引用
收藏
页码:767 / 770
页数:4
相关论文
共 50 条
  • [21] Serum anti-p53 antibodies in patients with squamous cell carcinoma of the esophagus: Comparison with p53 alterations and lymph node invasion
    Collet, B
    Raoul, JL
    LeBerre, N
    Heresbach, D
    Meritte, H
    Quillien, V
    DeCertaines, JD
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 11 (03) : 617 - 621
  • [22] ISOLATION AND CHARACTERIZATION OF A HUMAN P53 CDNA CLONE - EXPRESSION OF THE HUMAN P53 GENE
    MATLASHEWSKI, G
    LAMB, P
    PIM, D
    PEACOCK, J
    CRAWFORD, L
    BENCHIMOL, S
    EMBO JOURNAL, 1984, 3 (13): : 3257 - 3262
  • [23] GENDER COMPARISONS IN HUMAN LUNG-CANCER - ANALYSIS OF P53 MUTATIONS, ANTI-P53 SERUM ANTIBODIES AND C-ERBB-2 EXPRESSION
    GUINEE, DG
    TRAVIS, WD
    TRIVERS, GE
    DEBENEDETTI, VMG
    CAWLEY, H
    WELSH, JA
    BENNETT, WP
    JETT, J
    COLBY, TV
    TAZELAAR, H
    ABBONDANZO, SL
    PAIROLERO, P
    TRASTEK, V
    CAPORASO, NE
    LIOTTA, LA
    HARRIS, CC
    CARCINOGENESIS, 1995, 16 (05) : 993 - 1002
  • [24] Plasma p53 protein and anti-p53 antibody expression in vinyl chloride monomer workers in Taiwan
    Luo, JCJ
    Liu, HT
    Cheng, TJ
    Du, CL
    Wang, JD
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1999, 41 (06) : 521 - 526
  • [25] Detection of anti-p53 antibodies by ELISA using p53 synthetic or phage-displayed peptides
    Portefaix, JM
    Fanutti, C
    Granier, C
    Crapez, E
    Perham, R
    Grenier, J
    Pau, B
    Del Rio, M
    JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 259 (1-2) : 65 - 75
  • [26] Implications of p53 alterations and anti-p53 antibody response in head and neck squamous cell carcinomas
    Lavieille, JP
    Righini, C
    Reyt, E
    Brambilla, C
    Riva, C
    ORAL ONCOLOGY, 1998, 34 (02): : 84 - 92
  • [27] Comparison of anti-p53 antibodies in immunoblotting
    Turpeinen, M
    Serpi, R
    Rahkolin, M
    Vähäkangas, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (02) : 850 - 856
  • [28] Serum anti-p53 autoantibodies in patients with type 1 diabetes
    Di Cesare, E
    Previti, M
    Lombardo, F
    Di Benedetto, A
    Mazzù, N
    Romano, G
    De Luca, F
    Lasco, A
    Cucinotta, D
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2001, 31 (03): : 253 - 258
  • [29] Detection of preoperative serum anti-p53 antibodies in gastric cancer
    Nakajima, K
    Suzuki, T
    Shimada, H
    Hayashi, H
    Takeda, A
    Ochiai, T
    TUMOR BIOLOGY, 1999, 20 (03) : 147 - 152
  • [30] Anti-p53 autoantibodies in patients with IDDM
    Di Cesare, E
    Previti, M
    Lombardo, F
    Di Benedetto, A
    Romano, G
    De Luca, F
    Cucinotta, D
    DIABETOLOGIA, 1999, 42 : A97 - A97